Reports from a top AI company that it found and stopped attempted uses of its product to manufacture a potential bioweapon caught the attention of lawmakers in Washington this week. Meanwhile, President Trump wants to send $500 checks to about a million Obamacare enrollees. Anna Edney of Bloomberg News, Tami Luhby of CNN, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Sabrina Corlette of the Georgetown University Center on Health Insurance Reforms.
Not all older people need benzodiazepines, antibiotics, or daily aspirin — and taking them can carry increased risks.
States are spending rural health dollars on tech startups, betting that untested companies will succeed where doctors have vanished and hospitals have collapsed. Louisiana’s call for innovative technology drew more than 200 pitches, seeking from $250,000 to $3 million in seed money.
As state governments grapple with how to determine who’s sick enough to be excused from new Medicaid work requirements, some families are already struggling with what illnesses guarantee health coverage because of a disability.
Stat reporter Bob Herman joins “An Arm and a Leg” to discuss the impact of surging health insurance costs on businesses and their workers.
Native Hawaiians will have to comply with the new work requirements in President Donald Trump’s signature One Big Beautiful Bill Act, despite facing significant obstacles to employment and healthcare.
A nonprofit and a local public health agency are subsidizing marketplace health insurance for Austin music artists, even as shifting marketplace conditions make the program a more expensive proposition. It’s becoming a model for other cities and sectors.
Democrats and Republicans in Troy, New York, joined together to challenge a national Catholic health system determined to close the last birthing center in the county.
Senate and House Democrats say the Trump administration’s plan to collect patients’ medical data violates privacy and will discourage people from seeking medical care.
The agreements, covering issues like drug pricing, reducing the use of synthetic food dyes, and cutting back on insurance prior authorization rules, were announced with fanfare and touted as victories. But it’s not clear whether they’ll result in lasting change.
